Tumor induced osteomalacia

Revision as of 01:21, 18 January 2009 by Zorkun (talk | contribs)
Jump to navigation Jump to search
Tumor induced osteomalacia

WikiDoc Resources for Tumor induced osteomalacia

Articles

Most recent articles on Tumor induced osteomalacia

Most cited articles on Tumor induced osteomalacia

Review articles on Tumor induced osteomalacia

Articles on Tumor induced osteomalacia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tumor induced osteomalacia

Images of Tumor induced osteomalacia

Photos of Tumor induced osteomalacia

Podcasts & MP3s on Tumor induced osteomalacia

Videos on Tumor induced osteomalacia

Evidence Based Medicine

Cochrane Collaboration on Tumor induced osteomalacia

Bandolier on Tumor induced osteomalacia

TRIP on Tumor induced osteomalacia

Clinical Trials

Ongoing Trials on Tumor induced osteomalacia at Clinical Trials.gov

Trial results on Tumor induced osteomalacia

Clinical Trials on Tumor induced osteomalacia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tumor induced osteomalacia

NICE Guidance on Tumor induced osteomalacia

NHS PRODIGY Guidance

FDA on Tumor induced osteomalacia

CDC on Tumor induced osteomalacia

Books

Books on Tumor induced osteomalacia

News

Tumor induced osteomalacia in the news

Be alerted to news on Tumor induced osteomalacia

News trends on Tumor induced osteomalacia

Commentary

Blogs on Tumor induced osteomalacia

Definitions

Definitions of Tumor induced osteomalacia

Patient Resources / Community

Patient resources on Tumor induced osteomalacia

Discussion groups on Tumor induced osteomalacia

Patient Handouts on Tumor induced osteomalacia

Directions to Hospitals Treating Tumor induced osteomalacia

Risk calculators and risk factors for Tumor induced osteomalacia

Healthcare Provider Resources

Symptoms of Tumor induced osteomalacia

Causes & Risk Factors for Tumor induced osteomalacia

Diagnostic studies for Tumor induced osteomalacia

Treatment of Tumor induced osteomalacia

Continuing Medical Education (CME)

CME Programs on Tumor induced osteomalacia

International

Tumor induced osteomalacia en Espanol

Tumor induced osteomalacia en Francais

Business

Tumor induced osteomalacia in the Marketplace

Patents on Tumor induced osteomalacia

Experimental / Informatics

List of terms related to Tumor induced osteomalacia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Tumor induced osteomalacia (also known as oncogenic hypophosphatemic osteomalacia or oncogenic osteomalacia) is an uncommon disorder resulting in increased renal phosphate excretion, hypophosphatemia and osteomalacia.

Signs and symptoms

Adult patients have worsening myalgias, bone pains and fatigue which are followed by recurrent fractures. Children present with difficulty in walking, stunted growth and deformities of the skeleton (features of rickets)[1].

Diagnosis

Biochemical studies reveal hypophosphatemia, elevated alkaline phosphatase and low serum calcitriol (1, 25 dihydroxyvitamin D) levels. Routine laboratory tests do not include serum phosphate levels and this can result in considerable delay in diagnosis.

Pathogenesis

FGF-23 (fibroblast growth factor-23) inhibits phosphate transport in the renal tubule and reduces calcitriol production by the kidney. Tumor production of FGF-23[2], frizzled-related protein 4 [3]and matrix extracellular phosphoglycoprotein (MEPE)[4] have all been identified as possible causative agents for the hypophosphatemia.

Causative tumors

Tumor induced osteomalacia is usually referred to as a paraneoplastic phenomenon, however, the tumors are usually benign and the symptomatology is due to osteomalacia or rickets[5]. Seen most often are benign mesenchymal or mixed connective tissue tumors (commonly hemangiopericytomas). Association with malignant tumors has also been reported. Locating the tumor can prove to be difficult and may require whole body magnetic resonance imaging (MRI). Some of the tumors express somatostatin receptors and may be located by octreotide scanning.

Differential diagnosis

Serum chemistries are identical in tumor induced osteomalacia, X-linked hypophosphatemic rickets (XHR) and autosomal dominant hypophosphatemic rickets (ADHR). A negative family history can be useful in distinguishing tumor induced osteomalacia from XHR and ADHR. If necessary, genetic testing for PHEX (phosphate regulating gene with homologies to endopepetidase on the X-chromosome) can be used to conclusively diagnose XHR and testing for the FGF-23 gene will identify patients with ADHR.

Treatment

Resection of the tumor is the ideal treatment and results in correction of hypophosphatemia (and low calcitriol levels) within hours of resection. Resolution of skeletal abnormalities may take many months.

If the tumor cannot be located, treatment with calcitriol (1-3 µg/day) and phosphorus (1-4 g/day in divided doses) is instituted. Tumors which secrete somatostatin receptors may respond to treatment with octreotide

References

  1. Jan de Beur SM Tumor-induced osteomalacia JAMA 2005 Sep 14;294(10):1260-7 PMID:16160135
  2. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Shimada T; Mizutani S; Muto T; Yoneya T; Hino R; Takeda S; Takeuchi Y; Fujita T; Fukumoto S; Yamashita T Proc Natl Acad Sci U S A 2001 May 22;98(11):6500-5
  3. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent.Berndt T; Craig TA; Bowe AE; Vassiliadis J; Reczek D; Finnegan R; Jan De Beur SM; Schiavi SC; Kumar R J Clin Invest 2003 Sep;112(5):785-94
  4. MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia. Rowe PS; de Zoysa PA; Dong R; Wang HR; White KE; Econs MJ; Oudet CL Genomics 2000 Jul 1;67(1):54-68
  5. Carpenter TO Oncogenic osteomalacia—a complex dance of factors N Engl J Med. 2003 April 24:348(17):175-8 PMID: 12711747

Template:SIB


Template:WikiDoc Sources